PreventID® Lyme Borreliosis

The PreventID® Lyme Borreliosis is a qualitative, membrane-based immunological test (lateral flow assay) for the detection of IgG and IgM antibodies against Borrelia in whole blood, serum or plasma samples.

Classic rapid tests
Professional medicals
Whole blood
Serum
Plasma

PreventID® Lyme Borreliosis

Only for sale to professional users such as doctors, pharmacists, alternative practitioners and other medically trained personnel.

Tick-borne Lyme disease is easy to treat, especially if detected early.

Lyme disease is transmitted to humans through the bite of infected ticks of the genus Ixodes. The most common sign of infection is an expanding red area on the skin called erythema migrans, which appears at the site of the tick bite about a week after the bite. The rash is usually neither itchy nor painful. About 25–50 % of infected individuals do not develop a rash. Other early symptoms may include fever, headache, and fatigue. IgM antibodies develop within the first few weeks after infection, but may persist for months in the case of Lyme disease. IgG antibodies are formed about 1 month after infection and remain in the body for years.

Your benefits

  • Test result readable after 10 minutes
  • Rapid test has a high sensitivity and specificity
  • Easy handling

Hint

Only for sale to professional users such as doctors, pharmacists, alternative practitioners and other medically trained personnel.

Short Instruction PreventID Lyme Borreliosis

IgM

Relative sensitivity

95.5 %

Relative specificity

98.9 %

Detection limit

1:16


IgG

Relative sensitivity

94.4 %

Relative specificity

98.9 %

Detection limit

1:32

Search
Contact
To top